Document Detail

Long-term macrolide treatment for chronic respiratory disease.
MedLine Citation:
PMID:  23180583     Owner:  NLM     Status:  Publisher    
Long-term macrolide treatment was first shown to alter the natural history of diffuse panbronchiolitis (DPB) in the late '80s. Since then, macrolides have been demonstrated to exert anti-inflammatory and immunomodulatory activity in addition to being antimicrobial. Indeed, their spectrum of action extends to regulation of leukocyte function and production of inflammatory mediators, control of mucus hypersecretion, resolution of inflammation, and modulation of host defence mechanisms. As such, the potential benefit of macrolide antibiotics has been evaluated in a variety of chronic respiratory diseases. The best studied condition is cystic fibrosis (CF), in which there have been six randomized controlled trials showing evidence of benefit. However, most of the studies were limited by the small number of patients and the short follow-up. More recently, landmark studies have demonstrated the efficacy of azithromycin in reducing the risk of acute exacerbations in patients with chronic obstructive pulmonary disease (COPD), but optimal duration and dosing of macrolide treatment remain uncertain.With the exception of patients with DPB and CF, until clear evidence of efficacy is available, the long-term use of macrolide should be limited to highly selected patients after careful evaluation of benefit and harm, or in the context of randomized controlled clinical trials.
Paolo Spagnolo; Leonardo M Fabbri; Andrew Bush
Related Documents :
6600343 - A sign of symptomatic chronic cholecystitis on biliary scintigraphy.
12173083 - A new cannula with a flexible tip (swing tip) may improve the success rate of endoscopi...
17479933 - Outbreak of chikungunya on reunion island: early clinical and laboratory features in 15...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-11-22
Journal Detail:
Title:  The European respiratory journal : official journal of the European Society for Clinical Respiratory Physiology     Volume:  -     ISSN:  1399-3003     ISO Abbreviation:  Eur. Respir. J.     Publication Date:  2012 Nov 
Date Detail:
Created Date:  2012-11-27     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8803460     Medline TA:  Eur Respir J     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Dept of Medical and Surgical Sciences for Children and Adults, University of Modena and Reggio Emilia, Policlinico di Modena, Italy.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Targeting aurora kinases limits tumour growth through DNA damage-mediated senescence and blockade of...
Next Document:  Exercise tolerance with helium-hyperoxia versus hyperoxia in hypoxaemic patients with COPD.